Molecular analysis of ACF as a colorectal precancerous lesion

Molecular analysis of ACF as a colorectal precancerous lesion - Molecular analysis of ACF

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000005996

Enrollment

Registered

2011-07-31

Start date

2011-08-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Aberrant crypt foci

Interventions

Biopsy of ACF and normal colorectal mucosa

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Candidate patients have to meet all the following inclusion to participate in the study #1Patient with written informed consent is obtained #2 Patients with at least one ACF of colorectal mucosa

Exclusion criteria

Exclusion criteria: #1 Patients with bleeding tendency #2 Patients with Familial Adenomatous Polyposis and Hereditary Non-Polyposis Colorectal Cancer #3Patients with known allergy to methylene blue

Design outcomes

Primary

Measure	Time frame
To establish a molecule imaging system of ACF	—

Countries

Japan

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026